Cipta Sarana Medika Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp136 (market cap 268.02B, 36.96M 24h volume). The key difference: Trimegah Karya Pratama Tbk. is the larger of the two by market cap, and Trimegah Karya Pratama Tbk. is more actively traded (36.96M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | UVCR | |
|---|---|---|
Market Cap | 158.12B | 268.02B |
Volume | 8.21M | 36.96M |
Lot | 82.15K | 369.56K |
Turnover | 515.2M | 5.02B |
Average Price | 62.72 | 135.74 |
Value | 515.2M | 5.02B |
Indicative Equilibrium Price | 63 | 136 |
Indicative Equilibrium Volume | 1.33K | 2.08K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →